IIC
NVO

Ironwood Investment Counsel’s Novo Nordisk NVO Stock Holding History

Ironwood Investment Counsel’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,981
Closed -$206K – 271
2025
Q2 		$206K Buy
2,981
+40
+1% +$2.72K 0.03% 245
2025
Q1 		$204K Buy
2,941
+60
+2% +$4.96K 0.04% 232
2024
Q4 		$248K Sell
2,881
-323
-10% -$34.9K 0.04% 220
2024
Q3 		$382K Hold
3,204
– – 0.06% 190
2024
Q2 		$457K Hold
3,204
– – 0.08% 168
2024
Q1 		$411K Hold
3,204
– – 0.07% 184
2023
Q4 		$331K Sell
3,204
-254
-7% -$25.1K 0.06% 196
2023
Q3 		$314K Buy
3,458
+350
+11% +$30.8K 0.07% 191
2023
Q2 		$251K Sell
3,108
-292
-9% -$23.9K 0.06% 179
2023
Q1 		$271K Hold
3,400
– – 0.06% 174
2022
Q4 		$230K Buy
+3,400
New +$199K 0.06% 186
2022
Q3 		– Sell
-4,200
Closed -$234K – 192
2022
Q2 		$234K Hold
4,200
– – 0.07% 170
2022
Q1 		$233K Buy
+4,200
New +$216K 0.06% 183

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ironwood Investment Counsel's NVO Position: Q3 2025 in Review

Ironwood Investment Counsel sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 2,981 shares — an estimated $206K sold.

Ironwood Investment Counsel first reported a position in NVO in Q1 2022 and held it in 13 quarters. The position peaked at $457K in Q2 2024. 1,396 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Ironwood Investment Counsel reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Ironwood Investment Counsel sold 2,981 Novo Nordisk shares in Q3 2025, an estimated $206K.
  • Ironwood Investment Counsel first reported a position in Novo Nordisk in Q1 2022 and held it in 13 quarters.
  • Ironwood Investment Counsel's Novo Nordisk position peaked at $457K in Q2 2024.
  • 1,396 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Ironwood Investment Counsel's 13F filing for Q3 2025, filed 5 Nov 2025.